Amlodipine Besylate Tablet
Product Images NDC 67877-197

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 67877-197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine 10mg 90tab

Label for Amlodipine Besylate Tablets, USP 10 mg from Ascend Laboratories, LLC. The label includes dosage strength (10 mg) in a red box, product name, quantity of 90 tablets, and prescription use indication (Rx Only). It shows storage instructions, manufacturer details (Alkem Laboratories Ltd., India), and a barcode.*

FDA Label Image

Amlodipine 2 5mg 90tab

Label for Amlodipine Besylate Tablets USP 2.5 mg by Ascend Laboratories, LLC. The label states the dosage strength as 2.5 mg per tablet, with a quantity of 90 tablets in the package. It includes storage instructions, a barcode, and manufacturer info indicating Alkem Laboratories, Ltd., India, with distribution by Ascend Laboratories in New Jersey. The label is marked Rx only.*

FDA Label Image

Amlodipine 5mg 90tab

Label for Amlodipine Besylate Tablets USP 5 mg, oral tablets, Rx only, in a 90-tablet package. The label shows the Ascend Laboratories, LLC logo and includes storage instructions, manufacturer information (Alkem Laboratories Ltd., India), and a barcode. It is intended for human prescription use.*

FDA Label Image

Figure 2 (Amlodipine Fig)

A forest plot chart illustrating hazard ratios with 95% confidence intervals comparing Amlodipine versus placebo across various patient subgroups, including age, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI stent status. The horizontal axis represents hazard ratios ranging from 0.0 to 2.0.*

FDA Label Image

Figure 1 (Amlodipine Gra)

A Kaplan-Meier curve illustrating event rates over a 24-month period comparing Amlodipine to placebo. The graph plots event rate on the vertical axis against time in months on the horizontal axis. Two lines show that Amlodipine has a lower event rate than placebo. Numbers at risk are indicated below the time axis, and a statistical summary box shows a p-value of 0.003, hazard ratio of 0.691, and 95% confidence interval of 0.54 to 0.88.*

FDA Label Image

Amlodipine-str-2 (Amlodipine Str 2)

Chemical structure of amlodipine besylate, showing its molecular configuration with various functional groups including a chlorine-substituted aromatic ring and ester groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.